公开(公告)号：US12048699B2

公开(公告)日：2024-07-30

申请号：US17252400

申请日：2019-06-18

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Akihiro Ohashi ,  Kenichi Iwai ,  Tadahiro Nambu ,  Kazunori Yamanaka ,  Kentaro Otake ,  Huifeng Niu ,  Hyunjin Shin ,  Erik Michael Koenig

IPC: A61K31/519 ,  A61P35/00 ,  C12Q1/6886

CPC classification number: A61K31/519 ,  A61P35/00 ,  C12Q1/6886 ,  C12Q2600/106

Abstract: The present disclosure relates to methods useful for determining whether to treat cancer in a patient, and treating cancer in a patient, by administering a therapeutically effective amount of Compound 1 and/or tautomers thereof or a pharmaceutically acceptable salt or hydrate thereof.